Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation

Detalles Bibliográficos
Autores principales: Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486789/
https://www.ncbi.nlm.nih.gov/pubmed/28577044
http://dx.doi.org/10.1007/s00277-017-3032-8
_version_ 1783246331154792448
author Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
author_facet Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
author_sort Oka, Satoko
collection PubMed
description
format Online
Article
Text
id pubmed-5486789
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54867892017-07-11 Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation Oka, Satoko Ono, Kazuo Nohgawa, Masaharu Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2017-06-02 2017 /pmc/articles/PMC5486789/ /pubmed/28577044 http://dx.doi.org/10.1007/s00277-017-3032-8 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
title Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
title_full Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
title_fullStr Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
title_full_unstemmed Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
title_short Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
title_sort successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the jak2 v617f mutation
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486789/
https://www.ncbi.nlm.nih.gov/pubmed/28577044
http://dx.doi.org/10.1007/s00277-017-3032-8
work_keys_str_mv AT okasatoko successfultreatmentwithazacitidineforthesimultaneousoccurrenceofmultiplemyelomaandacutemyeloidleukemiawithconcomitantdel5qandthejak2v617fmutation
AT onokazuo successfultreatmentwithazacitidineforthesimultaneousoccurrenceofmultiplemyelomaandacutemyeloidleukemiawithconcomitantdel5qandthejak2v617fmutation
AT nohgawamasaharu successfultreatmentwithazacitidineforthesimultaneousoccurrenceofmultiplemyelomaandacutemyeloidleukemiawithconcomitantdel5qandthejak2v617fmutation

Ejemplares similares